glycyrrhizic acid has been researched along with Chronic Lung Injury in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Deng, J; Du, J; Gu, J; Jiang, B; Peng, G; Ran, X; Wen, D; Xia, F; Zhang, A | 1 |
Chen, C; Chen, J; Chen, Y; Dong, N; Feng, L; Liu, L; Qian, Y; Shi, Q; Wang, B | 1 |
2 other study(ies) available for glycyrrhizic acid and Chronic Lung Injury
Article | Year |
---|---|
Glycyrrhizin alleviates sepsis-induced acute respiratory distress syndrome via suppressing of HMGB1/TLR9 pathways and neutrophils extracellular traps formation.
Topics: Animals; Disease Models, Animal; Extracellular Traps; Glycyrrhizic Acid; HMGB1 Protein; Lung; Lung Injury; Mice; Myeloid Differentiation Factor 88; Neutrophils; Respiratory Distress Syndrome; Sepsis; Toll-Like Receptor 9 | 2022 |
Glycyrrhizin protects against particulate matter-induced lung injury via regulation of endoplasmic reticulum stress and NLRP3 inflammasome-mediated pyroptosis through Nrf2/HO-1/NQO1 signaling pathway.
Topics: Animals; Endoplasmic Reticulum Stress; Glycyrrhizic Acid; Humans; Inflammasomes; Lung Injury; Mice; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Particulate Matter; Pyroptosis; Signal Transduction | 2023 |